5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione
CAS: 146062-49-9
Ref. 3D-WFA06249
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
- 5-[[4-[2-(5-Ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-2,4-thiazolidinedione
- 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-
- MSDC 0160
- Mitoglitazone
- CAY 10415
5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione (5EPC) is a drug that inhibits tumor growth and has been used for the treatment of diabetes. It is an antidiabetic agent that binds to the receptor of soluble guanylate cyclase, which is responsible for regulating the production of cyclic guanosine monophosphate (cGMP). 5EPC has shown inhibitory effects on chronic kidney disease in patients who are not diabetic. Furthermore, it has been shown that 5EPC can be used in combination with dpp-iv inhibitors for the treatment of metabolic disorders.
Propiedades químicas
Consulta técnica sobre: 3D-WFA06249 5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
